Opportunities for patients to participate in research studies are an important component of the melanoma program. The team works to have clinical trials available to all patients. Some are national and others are Stony Brook’s own. For information, see Innovations & Research in Cancer. For specific clinical trial listings, see our Current Clinical Trials.
Hightlights of our current trials include:
- MSLT-II: This is an international trial evaluating the role of lymph node surgery in patients with melanoma.
- ECOG1609: A Phase III trial comparing Ipilimumab and high dose Interferon in patients with Stage III melanoma.
- Genetic Character of Melanoma and Correlation with Outcome: A study of tumor genetic profile and it's relationship to patient outcome.